Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exacerbations

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 10, 2023

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions
Cystic FibrosisCystic Fibrosis Pulmonary Exacerbation
Interventions
DRUG

Sodium Fusidate

Tablets

DRUG

Placebo

Tablets

Trial Locations (25)

10532

New York Medical College, Hawthorne

14642

University of Rochester Medical Center Strong Memorial, Rochester

15224

University of Pittsburgh Medical Center, Pittsburgh

21287

Johns Hopkins University, Baltimore

29425

Medical University of South Carolina, Charleston

32514

Nemours Children's Health - Pensacola, Pensacola

32610

University of Florida, Gainesville

32803

Central Florida Pulmonary Group, Orlando

33701

Johns Hopkins All Children's Hospital, St. Petersburg

37232

Vanderbilt University Medical Center, Nashville

40202

University Of Louisville, Louisville

44106

Rainbow Babies and Children's Hospital/Cleveland Medical Center, Cleveland

46202

Riley Hospital for Children, Indianapolis

48109

University of Michigan, Michigan Medicine, Ann Arbor

60093

Cystic Fibrosis Center of Chicago, Chicago

Cystic Fibrosis Center of Chicago, Northfield

63114

Washington University School of Medicine, St Louis

66160

University of Kansas Medical Center, Kansas City

68114

UNMC-Nebraska CF Pediatric Center, Omaha

73104

University of Oklahoma Health Sciences Center, Oklahoma City

75708

The University of Health Science Center at Tyler, Tyler

76104

Cook Children's Health Care System, Fort Worth

99204

Providence Medical Research Center, Spokane

04102

Maine Medical Center, Portland

07960

Gunnar H. Esiason Adult Cystic Fibrosis Center, Morristown

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Aceragen

INDUSTRY

NCT05641298 - Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exacerbations | Biotech Hunter | Biotech Hunter